Stanley-Laman Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-61,353	Closed	-$5.78M	–	224
2018 Q2	$5.78M	Sell	61,353 -1,164	-2%	-$110K	1.3%	15
2018 Q1	$5.07M	Sell	62,517 -2,416	-4%	-$196K	1.15%	20
2017 Q4	$5.79M	Sell	64,933 -8,293	-11%	-$739K	1.25%	14
2017 Q3	$6.82M	Buy	+73,226	New	+$6.82M	1.82%	3